SpectraCure AB (publ) (STO:SPEC)
Sweden · Delayed Price · Currency is SEK 0.0237
-0.0002 (-0.84%)
Sep 4, 2026, 5:23 PM CET
SpectraCure AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | -0.24 | - | - | - | 0.54 | - |
| -0.24 | - | - | - | 0.54 | - | |
Revenue Growth | - | - | - | - | -55.49% | - |
Cost of Revenue | -12.34 | -12.44 | -9.77 | -9.54 | -3.05 | -1.39 |
Gross Profit | 12.09 | 12.44 | 9.77 | 9.54 | 3.59 | 1.39 |
Selling, General & Admin | 35.41 | 36.66 | 31.62 | 30.91 | 28.72 | 27.76 |
Other Operating Expenses | 0.96 | 0.91 | -1.39 | -2.5 | -2.32 | -5.71 |
Operating Expenses | 66.37 | 67.7 | 32.86 | 31.07 | 29.27 | 24.71 |
Operating Income | -54.28 | -55.26 | -23.1 | -21.53 | -25.69 | -23.33 |
Interest Expense | -1.67 | -1.25 | -0.47 | -0.52 | -0.18 | -0.25 |
Interest & Investment Income | 0.23 | 0.23 | 1.21 | 1.95 | 0.54 | 0.22 |
Earnings From Equity Investments | - | - | -0.69 | -0.54 | - | - |
Currency Exchange Gain (Loss) | 0.23 | 0.23 | 0.04 | 0.06 | - | - |
Other Non Operating Income (Expenses) | - | - | 0 | - | - | - |
EBT Excluding Unusual Items | -55.49 | -56.05 | -23.01 | -20.59 | -25.33 | -23.36 |
Gain (Loss) on Sale of Assets | - | - | - | 0.12 | 0.02 | 0.01 |
Asset Writedown | - | - | - | - | -0.06 | - |
Pretax Income | -55.49 | -56.05 | -23.01 | -20.46 | -25.38 | -23.35 |
Income Tax Expense | 0.04 | 0.03 | -0.01 | -0.02 | - | -0.01 |
Net Income | -55.53 | -56.08 | -23 | -20.44 | -25.38 | -23.34 |
Net Income to Common | -55.53 | -56.08 | -23 | -20.44 | -25.38 | -23.34 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 819 | 283 | 97 | 97 | 97 | 97 |
Shares Outstanding (Diluted) | 819 | 283 | 97 | 97 | 97 | 97 |
Shares Change | 408.02% | 191.63% | - | - | - | 5.11% |
EPS (Basic) | -0.07 | -0.20 | -0.24 | -0.21 | -0.26 | -0.24 |
EPS (Diluted) | -0.07 | -0.20 | -0.24 | -0.21 | -0.26 | -0.24 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -32.28 | -24.03 | -21.25 | -18.68 | -23.52 | -18.77 |
Free Cash Flow Per Share | -0.04 | -0.09 | -0.22 | -0.19 | -0.24 | -0.19 |
Gross Margin | - | - | - | - | 665.12% | - |
Operating Margin | - | - | - | - | -4766.05% | - |
Profit Margin | - | - | - | - | -4708.53% | - |
Free Cash Flow Margin | - | - | - | - | -4363.82% | - |
EBITDA | -53.98 | -54.93 | -22.68 | -21.03 | -25.18 | -22.87 |
D&A For EBITDA | 0.3 | 0.34 | 0.42 | 0.51 | 0.51 | 0.46 |
EBIT | -54.28 | -55.26 | -23.1 | -21.53 | -25.69 | -23.33 |
Revenue as Reported | 0.63 | 0.87 | 1.53 | 2.84 | 2.94 | 5.75 |